Summit Trail Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.72M | Buy |
|
|||||
|
2025
Q2 | $1.19M | Buy |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $994K | Buy |
|
|||||
|
2024
Q3 | $1.46M | Buy |
|
|||||
|
2024
Q2 | $1.32M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Buy |
|
|||||
|
2023
Q4 | $912K | Sell |
|
|||||
|
2023
Q3 | $907K | Buy |
|
|||||
|
2023
Q2 | $765K | Buy |
|
|||||
|
2023
Q1 | $674K | Buy |
|
|||||
|
2022
Q4 | $478K | Buy |
|
|||||
|
2022
Q3 | $442K | Sell |
|
|||||
|
2022
Q2 | $525K | Buy |
|
|||||
|
2022
Q1 | $598K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $114K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $275K | Buy |
|